Abstract.
Objective and Design: The neutrophil elastase inhibitor MDL 101,146 was examined for its anti-arthritic effect and to determine the role of neutrophil elastase in collagen-induced arthritis and adjuvant arthritis.¶Material: The collagen-induced arthritis model was performed in female DA rats immunized on day 0 and 7 with chick type II collagen in Freund's incomplete adjuvant. Adjuvant arthritis was induced in female Lewis rats by an intradermal injection of heat-killed Mycobacterium tuberculosis H37RA.¶Methods: The clinical signs of arthritis were assessed, joint swelling was measured using calipers and bone degradation, new bone proliferation, pannus formation and cartilage degradation were evaluated histologically.¶Results: MDL 101,146 administered orally inhibited the severity of collagen-induced arthritis as measured by a reduction in clinical score and joint swelling. Histological evaluation demonstrated a bone and cartilage sparing effect of MDL 101,146 in the tibio-tarsal joint of animals with collagen-induced arthritis.¶Conclusions: These results suggest that destruction of the joint in collagen-induced arthritis is at least partially due to neutrophil elastase.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 17 June 1997; returned for revision 24 July 1997; accepted by W. B. van den Berg 16 September 1997
Rights and permissions
About this article
Cite this article
Janusz, M., Durham, S. Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146. Inflamm. res. 46, 503–508 (1997). https://doi.org/10.1007/s000110050233
Published:
Issue Date:
DOI: https://doi.org/10.1007/s000110050233